We are live on ! Find out more
UOTTAIMCU

University of Texas/Texas AM Investment Management Co (UTIMCO) Portfolio holdings

AUM $863M
1-Year Est. Return 30.35%
This Fund
S&P 500
This Quarter Est. Return
+9.85%
1 Year Est. Return
+30.35%
3 Year Est. Return
+68.34%
5 Year Est. Return
+24.17%
10 Year Est. Return
–
AUM
$96.1M
AUM Growth
+$70.2M
Cap. Flow
+$68.2M
Cap. Flow %
70.96%
Top 10 Hldgs %
98.45%
Holding
27
New
16
Increased
–
Reduced
1
Closed
3

Top Buys

Rank Stock Value
1
TSHA icon
Taysha Gene Therapies
TSHA
+$47M
2
CSTL icon
Castle Biosciences
CSTL
+$10.9M
3
IMTX icon
Immatics
IMTX
+$7.35M
4
TFFP
TFF Pharmaceuticals, Inc. Common Stock
TFFP
+$2.49M
5
CHRS icon
Coherus Oncology
CHRS
+$763K

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$853K
2
SYK icon
Stryker
SYK
+$685K
3
XYZ
Block Inc
XYZ
+$52K
4
VT icon
Vanguard Total World Stock ETF
VT
+$4.17K

Sector Composition

Rank Sector Weight
1 Healthcare 79.34%
2 Technology 4.85%
3 Consumer Discretionary 0.15%
4 Communication Services 0.1%
5 Utilities 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSHA icon
1
Taysha Gene Therapies
TSHA
$2.05B
$44.8M 46.63%
+2,000,000
New +$47M
VT icon
2
Vanguard Total World Stock ETF
VT
$81.4B
$14.6M 15.23%
181,506
-52
-0% -$4.17K
CSTL icon
3
Castle Biosciences
CSTL
$960M
$12.6M 13.15%
+245,527
New +$10.9M
IMTX icon
4
Immatics
IMTX
$1.33B
$7.4M 7.7%
+697,431
New +$7.35M
TXN icon
5
Texas Instruments
TXN
$253B
$4.57M 4.76%
32,000
– –
TFFP
6
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$4.08M 4.24%
+8,827
New +$2.49M
SOLY
7
DELISTED
Soliton, Inc.
SOLY
$3.25M 3.38%
425,000
– –
SYRE icon
8
Spyre Therapeutics
SYRE
$9.18B
$1.98M 2.06%
11,187
– –
CHRS icon
9
Coherus Oncology
CHRS
$181M
$753K 0.78%
+41,036
New +$763K
PHR icon
10
Phreesia
PHR
$758M
$493K 0.51%
+15,351
New +$457K
APEN
11
DELISTED
Apollo Endosurgery, Inc.
APEN
$472K 0.49%
279,037
– –
PLXP
12
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$202K 0.21%
62,673
– –
IAU icon
13
iShares Gold Trust
IAU
$65.4B
$115K 0.12%
+3,200
New +$117K
DIS icon
14
Walt Disney
DIS
$178B
$99K 0.1%
+800
New +$100K
HD icon
15
Home Depot
HD
$342B
$97K 0.1%
+350
New +$94.8K
ORCL icon
16
Oracle
ORCL
$442B
$90K 0.09%
+1,503
New +$85.4K
ACWI icon
17
iShares MSCI ACWI ETF
ACWI
$33.4B
$88K 0.09%
+1,106
New +$87.6K
EW icon
18
Edwards Lifesciences
EW
$53.6B
$67K 0.07%
+837
New +$65.3K
SRE icon
19
Sempra
SRE
$56.2B
$64K 0.07%
+1,074
New +$66.1K
DHR icon
20
Danaher
DHR
$145B
$53K 0.06%
+276
New +$49.1K
LXRX icon
21
Lexicon Pharmaceuticals
LXRX
$1.05B
$51K 0.05%
35,714
– –
NKE icon
22
Nike
NKE
$60.1B
$50K 0.05%
+400
New +$42.9K
BRO icon
23
Brown & Brown
BRO
$23.8B
$34K 0.04%
+753
New +$33.6K
POR icon
24
Portland General Electric
POR
$5.74B
$4K ﹤0.01%
118
– –
AMGN icon
25
Amgen
AMGN
$225B
– –
-3,615
Closed -$853K
1
2

Similar funds

WFAL
Wedbush Fund Advisers, LLC Pasadena, California $863M AUM
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
RWM
RMG Wealth Management Platteville, Wisconsin $866M AUM 11.95% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
HP
Havemeyer Place Greenwich, Connecticut $867M AUM
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s Q3 2020 Portfolio in Review

As of Q3 2020, University of Texas/Texas AM Investment Management Co (UTIMCO) held 27 positions worth $96.1M, up 271% from $25.9M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

University of Texas/Texas AM Investment Management Co (UTIMCO) deployed $68.2M of net new capital in Q3 2020, opening 16 new positions. Its largest new stake was Taysha Gene Therapies: 2,000,000 shares worth $44.8M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, up from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Total World Stock ETF, an estimated $4.17K trimmed.

  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s largest Q3 2020 buy was Taysha Gene Therapies: 2,000,000 shares worth $44.8M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s biggest Q3 2020 reduction was Vanguard Total World Stock ETF, cutting an estimated $4.17K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) fully exited Amgen in Q3 2020, selling an estimated $853K.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s ten largest holdings make up 98% of its $96.1M portfolio in Q3 2020.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) opened 16 new positions and closed 3 in Q3 2020.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s portfolio value rose 271% quarter-over-quarter to $96.1M.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q3 2020, filed 6 Nov 2020.